ISRAELI TRADE COMMISSION, STOCKHOLM
Of a total of 123,500 professional visitors, over 60% of visitors at MEDICA 2017 came from countries outside Germany, from 130 different countries. Among these were visitor groups with members who were the top of their field, from China, India, Columbia and Nepal, along with visitor groups from the most important markets for medical technology in Europe who have attended for years and years.
According to the German Medical Technology Association BVMed, the medical technology industry expects to see an increase of almost 6% in its global turnover, and this will be driven by dynamic developments in the export market. In comparison, domestic trade will experience a relatively low growth of 2.8%, predicted to result in overall turnover of 30.6 billion Euros. These are the outcomes of the latest survey of 106 German and foreign manufacturers.
To sum up the discussions from the other well-attended themed forums which were integrated into MEDICA, for example the MEDICA HEALTH IT FORUM or the MEDICA CONNECTED HEALTHCARE FORUM, as well as the innovative products presented by the exhibitors, we can state the following: Digitalization is penetrating all sectors of medical care, and this is a trend that is here to stay. Economic feasibility and easy handling of medical technology devices and products are top priorities in terms of ensuring sales. Any applications that make relevant information available at the point of care as quickly and easily as possible are in very high demand. Mobile computing programs on tablets and smartphones are examples of this, along with their apps. This leads us onto another trend: dematerialization. With more and more systems, devices and products, innovation is overwhelmingly based around new software solutions and less on hardware. This equipment is also becoming more compact and lighter, without any reduction in performance. An ultrasound system consisting solely of a combination of the transducer, a smartphone and an app was one of the product highlights at MEDICA 2017. Thanks to innovative development of the transducer, ultrasound-to-go has become an option even in cardiology, one of the most demanding disciplines.
A young Israeli-based company develops a new therapy technology for rehabilitation following stroke and other neurological impairments. The device, Intuitive Neuro-Motion Learning™, is designed by offering a viable cost-effective solution for post stroke “Home Users” patients, and patients suffering from other neurological disorders.
orlybar@salute.technology
Sion Medical Ltd. is a leading manufacturer of single-use skin cleansing and dermatologic treatment, advanced wound care, burns remedy and surgical solutions for the professional health care sector.
Sion Medical Ltd. is currently operating through five locations worldwide, two manufacturing sites in Israel, as well as additional sales and logistics divisions in Europe and North America (SIONBRANDS).
L-Mesitran is the leading brand in innovative and natural wound care solutions. The honey-based products are antibacterial, stimulate wound healing and are safe and cost effective.
The company has 25 years of experience in the production of Medical Devices and OTC Drugs. Sion Medical Ltd. is on the front line of Wound Care Management and Infection Prevention with a vast array of specialized products, this has allowed our customers to expand their product portfolio throughout the years.
The company focuses its attention on the development of skin asepsis solutions, generic creams, ointments and gels for topical dermatologic, burns and wound applications. Example products include, Sterile Lubricating Jelly, Zinc Paste Unna Boot, Honey, Skin Care, Lemon Glycerin, to mention a few.
The Company’s dedication to R&D has resulted in its ability to provide products that enhance the performance and delivery of active ingredients and improve personal health.
The Company’s Quality System is accredited to ISO 9001:2015, EN ISO 13485:2016, ISO 13485:2016 CMDCAS and in compliance with CFR Title 21 Parts 210, 211, 820. Our products bear the CE Mark certification.
yulie@sn-medical.com
Mennen Medical Ltd. is a leader in patient monitoring, diagnostic instrumentation and clinical information systems for hospital based cardiac catheterization, electrophysiology and critical care applications, with over 50 years as a vital signs monitoring technologies developer and manufacturer.
Mennen Medical’s monitoring solutions provide department to hospital data connectivity tailor-made to the institute’s requirements. The company’s headquarters are based in Israel, and includes two fully owned subsidiaries in the US (Mennen Medical Corporation – MMC)
MTRE – a fully owned subsidiary of Mennen Medical Group, is an advanced developer and manufacturer of innovative non-invasive solutions for body temperature management. These solutions enable healthcare providers to control & maintain a precise patient body temperature, thereby, paving the way for significant medical and economical benefits.
info@mmi.co.il
Medical Enterprises Group is a growing and dynamic medical device company. It has its headquarters in Amsterdam, The Netherlands, where sales and marketing activities are managed. Research and Development, technical support and clinical activities are managed from the facility in Israel.
Our R&D staff is a multifunctional team composed of physicists, electrical and mechanical engineers, software and QA experts.
The medical department includes trained physicians who provide medical support to Urology Departments around the world, and handle clinical trials and publications.
The company is focused on developing minimally invasive therapeutic technologies which provide benefits for both patient and healthcare system.
The company's leading product, Synergo®, offers an advanced treatment modality for patients suffering from non-muscle invasive bladder cancer.
synergo-med@planet.nl
Relays on the time continuum, HealthWatch Technologies is a sensor and analytics innovative medical device technology company based in Kfar Saba, Israel. It is focused on the development of next generation sensor technologies; and marketing and sales of its platform technological base for textile medical sensors to a wide variety of healthcare institutions.
Our MasterCaution® patented platform technology, together with its patient management system, has wide market applications both within and outside the hospital environs and is the first and only 12-lead ECG smart digital garment that is CE/FDA-cleared.
moran.f@personal-healthwatch.com
Privately-held and founded in 2013 GlucoMe is headquartered in Israel and serves diabetes patients, caregivers, and medical professionals worldwide.
Led by medical device, diabetes, and technology experts, the GlucoMe management team brings broad and multidisciplinary experience with proven records of success. Complementing the management are experienced and professional technical teams who together constitute a creative, caring and motivated industry-leading force.
Meet our team: http://www.glucome.com/about-us/team
www.glucome.com
info@glucome.com
DYN R&D was founded in 2002 as a development and commercialization subsidiary of DYN Diagnostics Group.
Since 1990, DYN Diagnostics has been one of the largest distributors in Israel of leading international brands in the fields of In-Vitro Diagnostics, Medical Devices, Over the Counter products, Disposables and more.
The innovative Startup atmosphere that pushes the Israeli market forward inspired DYN R&D to harness years of knowledge and experience into the world of research and development.
DYN Diagnostics professional reputation placed DYN R&D in the front row of opportunities and collaboration with opinion leaders, research facilities and health institutes.
Today, DYN R&D creates advanced solutions that correspond with the needs of Molecular Diagnostics and Medical Devices fields.
DYN R&D also specializes in Genetic Agriculture Marker Analysis.
Due to growing demands for solutions in the field of Agricultural Biotechnology, in 2008 DYN R&D has launched the Genotype® brand, set to offer unique DNA markers and smart breeding solutions.
We believe that our innovative perspective and long-term experience in these fields can help offering better and smarter options.
DYN R&D complies with the international standards of ISO 13485 and maintains a full quality management system.
bio@dyn.co.il
CNOGA Medical Ltd. is a privately held international company with headquarters in Israel and branch offices
in China and Brazil. Cnoga Medical developed and distributes innovative Non Invasive medical devices
for Diabetes & Cardiovascular disease management. Cnoga medical is the first company in the world that
developed a line of Noninvasive and pain-free products that comply with the highest accuracy and quality
standards. Using a camera real-time color image sensor and unique patent algorithm Cnoga medical manage
to analyze the vast amount of data and detect blood chromatic changes as a function body physiology this
enable Cnoga the capability to compute desired Bio Parameters in a non-invasive manner.
info@cnoga.com
Tonson Labs is the place where advanced technology fusion is created in order to provide solutions to the ‘nearly impossible’.
Our target market includes high-tech companies that develop and manufacture products to various sectors. Our clients look for extraordinary engineering capabilities in order to overcome the challenges presented by their customers as well as their competitors.
We are an international multi-technology research and development center based in Israel.
info@tonsonlabs.com
bo&bo Ltd. was founded by physiotherapists who worked hard to find ways to keep their patients motivated. Inspired by the slogan “fun as a method to achieve goals” they brought hi-tech products into the traditional physiotherapy clinic.
As experienced therapists, our products are planned and designed with both the trainer and the patient in mind. We have invested a lot of effort and thought to create simple and accessible systems that can be adjusted to any physical ability and challenge level.
Last year we successfully launched boboPRO in Israel, targeting the professional training and rehabilitation market – both institutions and personal trainers. Our customers already include leading hospitals, HMOs, physiotherapy clinics, personal trainers, and gyms.
We are currently developing supplementary products and solutions for home users.
info@bobo-balance.com
◄
1 / 1
►
MEDICA 2017
Israeli Exhibitors 2017